Plasma pTau181 concentrations are specifically elevated in AD,tracking closely with amyloid-PET and longitudinal cognitive decline, and are thought toreflect levels of amyloid-related tau hyperphosphorylation [15, 16]. The gene discussed is MAPT; the disease is Alzheimer disease.